Publication:

Expression Analysis of Macrodactyly Identifies Pleiotrophin Upregulation

Loading...
Thumbnail Image

Open/View Files

Date

2012

Journal Title

Journal ISSN

Volume Title

Publisher

Public Library of Science
The Harvard community has made this article openly available. Please share how this access benefits you.

Research Projects

Organizational Units

Journal Issue

Citation

Lau, Frank H., Fang Xia, Adam Kaplan, Felecia Cerrato, Arin K. Greene, Amir Taghinia, Chad A. Cowan, and Brian I. Labow. 2012. Expression analysis of macrodactyly identifies pleiotrophin upregulation. PLoS ONE 7(7): e40423.

Abstract

Macrodactyly is a rare family of congenital disorders characterized by the diffuse enlargement of 1 or more digits. Multiple tissue types within the affected digits are involved, but skeletal patterning and gross morphological features are preserved. Not all tissues are equally involved and there is marked heterogeneity with respect to clinical phenotype. The molecular mechanisms responsible for these growth disturbances offer unique insight into normal limb growth and development, in general. To date, no genes or loci have been implicated in the development of macrodactyly. In this study, we performed the first transcriptional profiling of macrodactyly tissue. We found that pleiotrophin (PTN) was significantly overexpressed across all our macrodactyly samples. The mitogenic functions of PTN correlate closely with the clinical characteristics of macrodactyly. PTN thus represents a promising target for further investigation into the etiology of overgrowth phenotypes.

Description

Research Data

Keywords

Biology, Computational Biology, Molecular Genetics, Gene Expression, Developmental Biology, Morphogenesis, Limb Development, Genetics, Human Genetics, Genomics, Genome Expression Analysis, Medicine, Surgery, Orthopedic Surgery, Pediatric Surgery, Reconstructive Surgery

Terms of Use

This article is made available under the terms and conditions applicable to Other Posted Material (LAA), as set forth at Terms of Service

Endorsement

Review

Supplemented By

Related Stories